The Fralin Life Sciences Institute at Virginia Tech's commitment to cancer research is evident in its support of scientists studying numerous aspects of the disease, including environmental factors that may play a role in cancer initiation, molecular and cellular events leading to the deregulation of cellular functions, and discovery and application of creative and cutting-edge technologies for cancer treatment. The institute encourages collaboration among researchers from wide-ranging backgrounds, including engineering, virology, biological sciences, and human nutrition, foods and exercise.
In 2009, Fralin Cancer Initiative Funds were used to establish the Fralin-VT Core Cancer Group, made up of Lead Investigators Elankumaran Subbiah, Chris Roberts, Dave Caudell, Liwu Li, and Carla Finkielstein. The group strengthens Virginia Tech’s cancer research impact by training undergraduate, graduate, and postdoctoral students in basic cancer research. The grouping of researchers from diverse backgrounds has led to new, multi-disciplinary projects that tackle the cancer problem from an innovative and progressive standpoint.